GOSELIN
AstraZeneca AB
| Research |
OneLook
Acronym Finder
|
| Serial Number | 78544038 |
| Registration Number | 3116308 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Cancellation Code | 2 |
| Domestic Representative | Wm. Charles Saunders |
| Attorney Name | Wm. Charles Saunders |
| Law Office Assigned | L70 |
| Employee Name | PAPPAS, MATTHEW JAMES |
Timeline
| 2005-01-07 | Application Filed |
| 2006-04-25 | Published for Opposition |
| 2006-07-18 | Location: PUBLICATION AND ISSUE SECTION |
| 2006-07-18 | Trademark Registered |
| 2013-02-22 | Cancelled |
| 2013-02-22 | Status: Dead/Cancelled |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  AstraZeneca AB |
| Address | SE-151 85 Södertälje SE |
| Legal Entity Type | Corporation |
| Legal Entity State | SE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparations for the treatment and prevention of cancer, none of these goods being antibiotics |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2005-01-19 | 1 NWAP I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2005-08-08 | 2 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2005-08-15 | 3 CNRT R:Renewal |
| NON-FINAL ACTION MAILED | 2005-08-16 | 4 CNRT F:First Action |
| PAPER RECEIVED | 2005-10-24 | 5 MAIL I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2005-10-24 | 6 CRFA I:Incoming Correspondence |
| AMENDMENT FROM APPLICANT ENTERED | 2005-11-08 | 7 ACEC I:Incoming Correspondence |
| NON-FINAL ACTION WRITTEN | 2005-11-22 | 8 CNRT R:Renewal |
| NON-FINAL ACTION MAILED | 2005-11-23 | 9 CNRT O:Outgoing Correspondence |
| PAPER RECEIVED | 2006-01-13 | 10 MAIL I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2006-01-13 | 11 CRFA I:Incoming Correspondence |
| AMENDMENT FROM APPLICANT ENTERED | 2006-02-01 | 12 ACEC I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2006-02-18 | 13 CNSA O:Outgoing Correspondence |
| ASSIGNED TO LIE | 2006-02-24 | 14 ALIE A:Allowance for Publication |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2006-03-03 | 15 PREV O:Outgoing Correspondence |
| NOTICE OF PUBLICATION | 2006-04-05 | 16 NPUB O:Outgoing Correspondence |
| PUBLISHED FOR OPPOSITION | 2006-04-25 | 17 PUBO A:Allowance for Publication |
| REGISTERED-PRINCIPAL REGISTER | 2006-07-18 | 18 R.PR A:Allowance for Publication |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2007-07-23 | 19 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2007-07-23 | 20 ARAA I:Incoming Correspondence |
| CANCELLED SEC. 8 (6-YR) | 2013-02-22 | 21 C8.. O:Outgoing Correspondence |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 GOSELIN 78544038 3116308 Dead/Cancelled |
AstraZeneca AB 2005-01-07 |
 GOSELIN 76150031 not registered Dead/Abandoned |
AstraZeneca AB 2000-10-19 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 